About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
En1tm8.1Alj
targeted mutation 8.1, Alexandra L Joyner
MGI:3789091
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
En1tm2(cre)Wrst/En1tm8.1Alj involves: 129/Sv * Black Swiss * C57BL/6 * SJL MGI:3789299
cn2
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm7.1Alj
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * 129X1/SvJ * Swiss Webster MGI:4421427
cn3
En1tm1Alj/En1tm8.1Alj
En2tm6Alj/En2+
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * Swiss Webster MGI:4421456
cn4
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm6Alj
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
involves: 129S2/SvPas * 129S6/SvEvTac * Swiss Webster MGI:4421433
cn5
En1tm8.1Alj/En1+
En2tm6Alj/En2+
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
involves: 129S6/SvEvTac * Swiss Webster MGI:4421432
cn6
En1tm2(cre)Wrst/En1tm8.1Alj
En2tm2Alj/En2+
involves: 129/Sv * Black Swiss * C57BL/6 * SJL * Swiss Webster MGI:3789300
cn7
En1tm2(cre)Wrst/En1tm8.1Alj
En2tm2Alj/En2tm2Alj
involves: 129/Sv * Black Swiss * C57BL/6 * SJL * Swiss Webster MGI:3789301
cx8
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm7.1Alj
involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * 129X1/SvJ * Swiss Webster MGI:4421431


Genotype
MGI:3789299
cn1
Allelic
Composition
En1tm2(cre)Wrst/En1tm8.1Alj
Genetic
Background
involves: 129/Sv * Black Swiss * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm2(cre)Wrst mutation (1 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• in most adult mice, mild foliation defect is observed
• fissure between anterior-most folia I/II and III either fails to form or is shallower than normal in most animals
• at E18.5, vermis may be slightly delayed in forming folia
• overall size in some mutants is slightly reduced relative to wild-type at E18.5




Genotype
MGI:4421427
cn2
Allelic
Composition
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm7.1Alj
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * 129X1/SvJ * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm1Alj mutation (2 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm1Alj mutation (1 available); any En2 mutation (104 available)
En2tm7.1Alj mutation (0 available); any En2 mutation (104 available)
Gt(ROSA)26Sortm1(cre/ERT2)Alj mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• when given tamoxifen at E13.5 or E14. the hemisphere phenotype is more severe than in double mutants that do not express Cre
• when given tamoxifen at E13.5 or E14. the vermis phenotype is more severe than in double mutants that do not express Cre




Genotype
MGI:4421456
cn3
Allelic
Composition
En1tm1Alj/En1tm8.1Alj
En2tm6Alj/En2+
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm1Alj mutation (2 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm6Alj mutation (1 available); any En2 mutation (104 available)
Gt(ROSA)26Sortm1(cre/ERT2)Alj mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• when given tamoxifen at E10.5, at P21 the anterior region (lobules I-V) is reduced and the central region (lobules VI-VII) is preferentially expanded.
• when tamoxifen is given at E10.5, at P21 lobule VIII extends more laterally than normal, as do lobules I-V but only on one side




Genotype
MGI:4421433
cn4
Allelic
Composition
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm6Alj
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S2/SvPas * 129S6/SvEvTac * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm1Alj mutation (2 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm1Alj mutation (1 available); any En2 mutation (104 available)
En2tm6Alj mutation (1 available); any En2 mutation (104 available)
Gt(ROSA)26Sortm1(cre/ERT2)Alj mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• tamoxifen treatment at E9.5, but not at E10.5, results in death at birth

nervous system
• when tamoxifen treated at E10.5, at P2 proliferation is similar in the anterior and central lobules, unlike in wild-type mice
• a major deletion of the midbrain is seen when tamoxifen is given at E9.5, but not when given at E10.5
• a major deletion of the medial cerebellum is seen when tamoxifen is given at E9.5 but not when given at E10.5
• when given tamoxifen at E10.5, at P14 the distinction between the vermis and the hemispheres is not apparent
• when given tamoxifen at E10.5, at E12.5 the cerebellar primordium is reduced in size
• when tamoxifen treated at E10.5, development of the vermis prepyramidal fissure is delayed and the order of fissure initiation is altered
• when given tamoxifen at E10.5, at P14 cerebellar foliation patterns are disrupted
• when given tamoxifen at E13.5 or E14.5, foliation defects in adults are less severe than when tamoxifen is given at E10.5
• when tamoxifen treated at E10.5, at E18.5 the thickness of the external granule layer was 1.5-2 times greater in the mutants than in wild types
• when tamoxifen treated at E10.5, at P2 the thickness of the external granule layer is similar in the lobules IV/V and VI unlike in wild-type mice
• when tamoxifen treated at E10.5, at P2 thickness is similar to that at E18.5 and thinner than in the controls.
• when given tamoxifen at E13.5 or E14.5, in adults the preculminate fissure is absent (between I-II and III) as lobules I-III are fused
• when given tamoxifen at E10.5, at P3 the depth of the primary fissure is increased relative to the intercrural fissure
• when given tamoxifen at E10.5, at P14 the anterior region (lobules I-V) is reduced and the central region (lobules VI-VII) is preferentially expanded
• when tamoxifen is given at E10.5, at P14, unlike in wild type, the remnants of lobules I-V extend into the hemispheres
• when tamoxifen is given at E10.5, at P14 remnants of the vermis, specific anterior and posterior regions, are maintained more laterally than in wild-type
• when given tamoxifen at E10.5, at P14 in some mutants lobule VIII is diminished more medially than lobule IX rather than the opposite as occurs in wild-type
• when tamoxifen treated at E10.5, at P2 lobules I - V are smaller and lobule VI is much larger than in wild-type
• when tamoxifen is given at E13.5 or E14.5, in adults lobule VIII is shifted posterior and fused with dorsal lobule IX
• when tamoxifen treated at E10.5, at P2 the thickness of the external granule layer is similar in the lobules IV/V and VI unlike in wild-type mice
• when given tamoxifen at E10.5, at P14 lobules VI-VII occupy a greater proportion of the vermis than in wild-type
• when given tamoxifen at E10.5, at P14 lobules VIII-IX occupy a smaller proportion of the vermis than in wild-type
• when given tamoxifen at E13.5 or E14.5, in adults lobules I-III are fused into one lobule
• when tamoxifen treated at E10.5, at P2 overall size of each region, and thus total number of cells, is greatly reduced
• when given tamoxifen, at P3 the cerebellum is smaller compared to controls

cellular
• when tamoxifen treated at E10.5, at P2 proliferation is similar in the anterior and central lobules, unlike in wild-type mice




Genotype
MGI:4421432
cn5
Allelic
Composition
En1tm8.1Alj/En1+
En2tm6Alj/En2+
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S6/SvEvTac * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm6Alj mutation (1 available); any En2 mutation (104 available)
Gt(ROSA)26Sortm1(cre/ERT2)Alj mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• when tamoxifen is given at E13.5 or E14.5 in adult preculminate (between I-II and III) as lobules I-III are fused
• when tamoxifen is given at E10.5, at P14 lobules VI-VII occupied a greater proportion of the vermis than in wild-type
• when tamoxifen is given at E10.5, at P14 lobules VIII-IX occupied a smaller proportion of the vermis than in wild-type
• when tamoxifen is given at E13.5 or E14.5 in adult the vermis has a foliation pattern that was a milder version than that observed in tamoxifen at 10.5 mutants
• when tamoxifen is given at E13.5 or E14.5 in adult posterior region lobule VIII is shifted posterior and fused with dorsal lobule IX.
• when tamoxifen is given at E13.5 or E14.5 in adult lobules I-V and VIII/IX of the vermis were present more laterally than normal tamoxifen at E13.5 or E14.5 in adult lobules I-III were fused into one lobule




Genotype
MGI:3789300
cn6
Allelic
Composition
En1tm2(cre)Wrst/En1tm8.1Alj
En2tm2Alj/En2+
Genetic
Background
involves: 129/Sv * Black Swiss * C57BL/6 * SJL * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm2(cre)Wrst mutation (1 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm2Alj mutation (0 available); any En2 mutation (104 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• absent at E18.5
• reduced in size at E18.5
• at E18.5, no cerebellum is present




Genotype
MGI:3789301
cn7
Allelic
Composition
En1tm2(cre)Wrst/En1tm8.1Alj
En2tm2Alj/En2tm2Alj
Genetic
Background
involves: 129/Sv * Black Swiss * C57BL/6 * SJL * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm2(cre)Wrst mutation (1 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm2Alj mutation (0 available); any En2 mutation (104 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• absent at E18.5
• absent at E18.5
• at E18.5, no cerebellum is present




Genotype
MGI:4421431
cx8
Allelic
Composition
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm7.1Alj
Genetic
Background
involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * 129X1/SvJ * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm1Alj mutation (2 available); any En1 mutation (34 available)
En1tm8.1Alj mutation (1 available); any En1 mutation (34 available)
En2tm1Alj mutation (1 available); any En2 mutation (104 available)
En2tm7.1Alj mutation (0 available); any En2 mutation (104 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• in the hemispheres, CrusII and Paramedian are only partially separated.
• in adults, only one or two major anterior lobules are present, and lobule VIII is very small and fused with dorsal lobule IX.





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory